IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide.
about
A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease.Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.Decreased Expression of Sphingosine-1-Phosphate Receptor 1 in the Blood Leukocyte of Rheumatoid Arthritis Patients
P2860
IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@en
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@nl
type
label
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@en
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@nl
prefLabel
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@en
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@nl
P2093
P2860
P356
P1433
P1476
IL-22-producing CD4+T cells in ...... methotrexate and leflunomide.
@en
P2093
P2860
P2888
P356
10.1038/SREP41143
P407
P577
2017-01-24T00:00:00Z